Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

OGI

OrganiGram Holdings Inc

Dollar change -0.0328
Percentage change -3.22	%

Mar 13 • 04:00PM ET

0.9872

-0.0328-3.22%

Healthcare • Drug Manufacturers - Specialty & Generic • Canada • NASD

Data

Timeframe

Analyst Consensus (5)Strong BuyDec 18, 2024

Low Target$1.40+41.82%Dec 2025

Avg Target$1.98+100.57%Dec 2025

High Target$2.43+146.15%Dec 2025

Target Price and Recommendations

4 Analysts

Strong Buy: 4

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Consensus: Strong Buy (1.00)

Dec 18, 2024

EPS Performance and Forecast

Currency: USD	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25
Estimate	—	-0.06	-0.06	-0.05	-0.06	-0.05	-0.11	—	-0.02	-0.03	-0.02	-0.01
# of Analysts	7	5	5	7	7	4	2	—	3	3	3	3
Reported	-0.03	-0.02	-0.06	0.06	-0.06	-2.01	-0.30	—	-0.14	—	—	—
Surprise	—	0.04 -61.17%	0.00 -3.44%	0.12 -217.88%	-0.00 4.87%	-1.96 3.63K%	-0.20 177.76%	—	-0.12 495.74%	—	—	—

GAAP EPS Performance and Forecast

Currency: USD	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25
Estimate	—	-0.06	-0.06	-0.05	-0.06	-0.05	-0.10	—	-0.02	-0.03	-0.02	-0.01
# of Analysts	7	5	5	7	7	4	1	—	3	3	3	3
Reported	-0.03	-0.02	-0.06	0.06	-0.06	-2.01	-0.30	—	-0.14	—	—	—
Surprise	—	0.04 -61.17%	0.00 -3.44%	0.12 -217.88%	-0.00 4.87%	-1.96 3.63K%	-0.20 197.56%	—	-0.12 495.74%	—	—	—

Revenue Performance and Forecast

Currency: USD	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25
Estimate	—	26.56M	32.65M	32.08M	32.48M	31.82M	29.66M	—	33.39M	42.88M	45.70M	48.38M
# of Analysts	9	10	10	10	10	9	3	—	4	4	4	4
Reported	25.24M	28.97M	33.50M	32.32M	29.36M	24.89M	34.51M	—	29.85M	—	—	—
Surprise	—	2.41M 9.07%	855.50K 2.62%	238.70K 0.74%	-3.13M -9.62%	-6.93M -21.79%	4.86M 16.37%	—	-3.54M -10.60%	—	—	—

Peers: TLRY CGC CRON ACB SNDL GRWG

| Held by: YOLO DFIS DFIC DFAX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.38	Insider Own	34.41%	Shs Outstand	126.16M	Perf Week	-8.59%
Market Cap	124.60M	Forward P/E	-	EPS next Y	-0.02	Insider Trans	0.00%	Shs Float	82.78M	Perf Month	-31.44%
Income	-38.42M	PEG	-	EPS next Q	-0.03	Inst Own	6.36%	Short Float	5.19%	Perf Quarter	-37.52%
Sales	121.24M	P/S	1.03	EPS this Y	38.82%	Inst Trans	-2.70%	Short Ratio	4.29	Perf Half Y	-46.05%
Book/sh	1.78	P/B	0.55	EPS next Y	83.94%	ROA	-13.72%	Short Interest	4.30M	Perf Year	-49.37%
Cash/sh	0.39	P/C	2.52	EPS next 5Y	-	ROE	-18.27%	52W Range	0.96 - 2.91	Perf YTD	-38.68%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-11.39%	ROI	-16.64%	52W High	-66.08%	Beta	1.09
Dividend TTM	-	Quick Ratio	1.85	Sales past 5Y	17.89%	Gross Margin	-2.58%	52W Low	2.83%	ATR (14)	0.08
Dividend Ex-Date	-	Current Ratio	3.36	EPS Y/Y TTM	84.56%	Oper. Margin	-49.03%	RSI (14)	29.09	Volatility	6.11% 6.62%
Employees	898	Debt/Eq	0.03	Sales Y/Y TTM	5.85%	Profit Margin	-31.69%	Recom	1.40	Target Price	1.98
Option/Short	Yes / Yes	LT Debt/Eq	0.03	EPS Q/Q	-1.33%	Payout	-	Rel Volume	0.68	Prev Close	1.02
Sales Surprise	-10.60%	EPS Surprise	-495.74%	Sales Q/Q	14.16%	Earnings	Feb 11 BMO	Avg Volume	1.00M	Price	0.99
SMA20	-14.77%	SMA50	-29.80%	SMA200	-38.59%	Trades		Volume	679,876	Change	-3.22%

Date	Action	Analyst	Rating Change
Jul-17-24	Resumed	Canaccord Genuity	Speculative Buy
Apr-15-24	Upgrade	Alliance Global Partners	Neutral → Buy
Jan-13-23	Upgrade	Stifel	Hold → Buy
Jan-12-22	Upgrade	Canaccord Genuity	Hold → Speculative Buy
May-11-21	Upgrade	CIBC	Sector Underperform → Neutral
Apr-14-21	Downgrade	CIBC	Neutral → Sector Underperform
Apr-08-21	Upgrade	BMO Capital Markets	Underperform → Market Perform
Mar-10-21	Downgrade	BMO Capital Markets	Market Perform → Underperform
Jan-13-21	Downgrade	Canaccord Genuity	Speculative Buy → Hold
Jan-13-21	Downgrade	Alliance Global Partners	Buy → Neutral
Jul-07-20	Initiated	Alliance Global Partners	Buy
Jan-15-20	Upgrade	Raymond James	Mkt Perform → Outperform
Jan-13-20	Initiated	BofA/Merrill	Underperform
Jan-09-20	Downgrade	Raymond James	Outperform → Mkt Perform
Nov-12-19	Downgrade	BMO Capital Markets	Outperform → Market Perform
Nov-05-19	Initiated	Cantor Fitzgerald	Overweight
Oct-11-19	Upgrade	Jefferies	Hold → Buy

Show Previous Ratings

Mar-10-25 08:36AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive) -5.66%
Mar-03-25 06:00AM	Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment (Business Wire) -6.96%
Feb-18-25 04:10PM	Organigram Holdings Inc. (OGI): A Bull Case Theory (Insider Monkey) +7.09%
Feb-12-25 02:05AM	OrganiGram Holdings Inc (OGI) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... (GuruFocus.com) -6.25%
Feb-11-25 10:15AM	Organigram (OGI) Q1 2025 Earnings Call Transcript (Motley Fool) -16.76%
08:35AM	Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.Finviz Elite
08:35AM	OrganiGram (OGI) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
07:34AM	OrganiGram: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	Organigram Reports First Quarter Fiscal 2025 Results (Business Wire)
Feb-04-25 06:00PM	Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025 (Business Wire) +7.28%
Dec-30-24 05:16PM	Why OrganiGram (OGI) Is Among the Best Pot Stocks to Invest in According to Analysts? (Insider Monkey)
Dec-20-24 09:05AM	Organigram Reports Fourth Quarter and Fiscal 2024 Results (Business Wire) +6.85%
Dec-19-24 02:00AM	OrganiGram Holdings Inc (OGI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Dec-18-24 01:45PM	Organigram (OGI) Q4 2024 Earnings Call Transcript (Motley Fool) -8.70%
09:25AM	OrganiGram: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
06:27AM	Organigram Acquires Motif Labs, Becomes Canadas Largest Cannabis Company (TipRanks)
06:00AM	Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.Finviz Elite
06:00AM	Organigram Reports Fourth Quarter and Fiscal 2024 Results (Business Wire)
Dec-11-24 06:00AM	Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024 (Business Wire)
Dec-09-24 10:06AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Dec-06-24 09:37AM	Canadian Investment Regulatory Organization Trade Resumption - OGI (PR Newswire) +10.34%
09:30AM	Canadian Investment Regulatory Organization Trading Halt - OGI (PR Newswire)
09:17AM	Organigram Acquires Motif, Becoming Canada's Largest Cannabis Company by Market Share (Business Wire)
Nov-26-24 06:00AM	Organigram Launches FAST Nanoemulsion Gummies (Business Wire) -6.96%
Sep-08-24 09:14PM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Sep-03-24 06:00AM	Organigram Closes Second Tranche of Previously Announced BAT Private Placement Investment (Business Wire)
Aug-13-24 04:00PM	Organigram (OGI) Q3 2024 Earnings Call Transcript (Motley Fool) +25.69%
07:19AM	OrganiGram: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	Organigram Reports Third Quarter Fiscal 2024 Results (Business Wire)
Aug-07-24 06:00AM	Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology (Business Wire)
Aug-06-24 06:00AM	Organigram to Report Third Quarter Fiscal 2024 Results on August 13, 2024 (Business Wire) +6.99%
Aug-05-24 04:06PM	The 3 Best Cannabis Stocks to Buy in August 2024 (InvestorPlace)
06:00AM	Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.Finviz Elite
Jul-29-24 06:00AM	Organigram Announces Appointment of Craig Harris to Board of Directors (Business Wire)
Jul-24-24 06:00AM	Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into Phylos (Business Wire) -7.41%
Jul-23-24 09:51AM	US, Canadian pot firms eye Germany for growth as market stagnates at home (Reuters)
Jul-15-24 11:00AM	3 Undervalued Stock Gems Selling for 50 Cents on the Dollar (InvestorPlace)
Jul-01-24 09:07PM	3 Iconic Brands Offering Both 5% Yields and 50% Upside at Current P/Es (InvestorPlace)
Jun-25-24 08:00AM	Organigram Invests in Sanity Group, a Leading German Cannabis Company (Business Wire) -5.10%
May-28-24 06:00AM	Organigram Signs Three Year Supply Agreement with Avida Medical in UK (Business Wire)
May-14-24 06:15PM	Organigram (OGI) Q2 2024 Earnings Call Transcript (Motley Fool) +5.18%
01:55PM	OGI Stock Earnings: OrganiGram Holdings Misses EPS for Q2 2024 (InvestorPlace)
07:22AM	OrganiGram: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	Organigram Reports Second Quarter Fiscal 2024 Results (Business Wire)
May-08-24 08:00AM	Organigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024 (Business Wire)
Apr-27-24 06:15AM	The Top 3 Cannabis Stocks to Buy in April 2024 (InvestorPlace)
Apr-26-24 09:40AM	Are Medical Stocks Lagging OrganiGram (OGI) This Year? (Zacks)
Apr-08-24 06:00AM	Organigram Recognized for Executive Gender Diversity by the Globe & Mails Women Lead Here Report for the Fourth Consecutive Year (Business Wire)
Apr-03-24 08:06AM	Organigrams Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales (Business Wire) +12.25%
Apr-02-24 08:51AM	Organigram Successfully Closes Previously Announced Underwritten Public Offering (Business Wire)
Mar-28-24 08:52AM	Why OrganiGram (OGI) Might Surprise This Earnings Season (Zacks) -6.32%
Mar-27-24 08:56AM	Organigram Announces Pricing of Overnight Marketed Public Offering (Business Wire) -14.37%
Mar-26-24 07:06PM	Organigram Announces Launch of Overnight Marketed Public Offering (Business Wire) +6.35%
01:36PM	Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment (Business Wire)
Mar-22-24 07:00PM	Organigram Receives Health Canadas Final Redetermination on Jolts (Business Wire) +8.37% -7.35%
Mar-21-24 04:05PM	Finding the Next Big Winners: 3 Stocks You Can Snag for Under $5 (InvestorPlace)
Feb-28-24 08:00AM	Organigram Applauds the Standing Committee on Finances Recommendation on Excise Duty (Business Wire) -5.09%
Feb-22-24 01:20PM	12 Best Marijuana Stocks To Invest In (Insider Monkey)
Feb-20-24 01:27PM	3 Millionaire-Maker Cannabis Penny Stocks to Buy in February 2024 (InvestorPlace) -5.05%
Feb-14-24 09:12AM	OrganiGram Holdings Inc. (NASDAQ:OGI) Q1 2024 Earnings Call Transcript (Insider Monkey)
Feb-13-24 11:30AM	Organigram (OGI) Q1 2024 Earnings Call Transcript (Motley Fool) -13.55%
07:43AM	OrganiGram: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	Organigram Reports First Quarter Fiscal 2024 Results (Business Wire)
Feb-07-24 06:00AM	Organigram to Report First Quarter Fiscal 2024 Results on February 13, 2024 (Business Wire)
Jan-31-24 06:00AM	Organigram Completes First Shipment to Germany, Extending its International Reach (Business Wire)
Jan-29-24 06:30AM	7 Cannabis Stocks to Sell as the Industry Faces Legal Uncertainty in 2024 (InvestorPlace)
Jan-28-24 05:02PM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Jan-24-24 06:00AM	Organigram Announces the First Tranche Closing from BAT Investment (Business Wire) -8.51%
Jan-19-24 06:00AM	Organigram Announces Appointment of Karina Gehring to Board of Directors (Business Wire) +10.71%
Jan-18-24 08:00PM	Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of C$124.6 Million Investment from BAT (Business Wire) -5.08%
Dec-29-23 06:35PM	11 Cheap Pot Stocks to Buy (Insider Monkey) -7.09%
06:00AM	Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting (Business Wire)
Dec-27-23 06:37PM	12 Most Profitable Pot Stocks Now (Insider Monkey)
Dec-19-23 02:41PM	13 Best Hemp Stocks To Buy Now (Insider Monkey)
01:01PM	OrganiGram: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
12:52PM	OGI Stock Earnings: OrganiGram Holdings Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
06:00AM	Organigram Reports Fiscal 2023 Results1 (Business Wire)
Dec-18-23 01:37PM	12 Best CBD Stocks To Buy Now (Insider Monkey)
06:00AM	Organigram Announces Appointment of Greg Guyatt as Chief Financial Officer (Business Wire)
Dec-14-23 07:48PM	Budding Potential: 3 Cannabis Stocks Poised for Growth in 2024 (InvestorPlace)
06:00AM	Organigram to Report Fourth Quarter and Fiscal 2023 Results on December 19, 2023 (Business Wire)
Dec-13-23 06:00AM	Organigram Wins KIND Magazines Innovation of the Year for SHRED X Rip-Strips Hash (Business Wire) +5.56%
Dec-07-23 11:15PM	The 3 Best Cannabis Stocks to Buy in December (InvestorPlace)
Nov-29-23 05:49PM	If You Can Only Buy One Cannabis Stock in December, It Better Be One of These 3 Names (InvestorPlace)
Nov-28-23 01:00PM	3 Underperforming Cannabis Stocks You Better Not Be Buying (InvestorPlace)
06:00AM	Organigram Increases Investment in Phylos After Successful Milestone Achievement (Business Wire)
Nov-12-23 05:44PM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Nov-10-23 06:00AM	Organigram Announces Interim Chief Financial Officer (Business Wire) +6.03%
Nov-06-23 09:21AM	Morning Brew: Disney Appoints PepsiCo CFO, Vanguard Exits China, and Organigram Secures Investment (GuruFocus.com) +18.97%
08:48AM	Midday movers: Tesla, BioNTech, Berkshire Hathaway and more (Investing.com)
06:00AM	Organigram Announces C$124.6 Million Investment from BAT and Creation of Jupiter Strategic Investment Pool (Business Wire)
Oct-18-23 06:00AM	Organigram Provides Corporate Update (Business Wire) -5.00%
Oct-11-23 08:00PM	Organigram Holdings Inc. Files Final Base Shelf Prospectus (Business Wire)
Oct-08-23 08:26PM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Sep-25-23 08:00PM	Organigram Holdings Inc. Files Preliminary Base Shelf Prospectus (Business Wire)
Sep-11-23 06:47PM	Why Marijuana Stocks Triumphed on Monday (Motley Fool) +17.83%
Sep-01-23 06:00PM	Organigram Announces Resignation of Board Member (Business Wire) -6.10%
Aug-28-23 06:00AM	Organigram Launches First Range of THCV Products Derived from Moncton-Grown Whole Flower (Business Wire)
Aug-21-23 07:00AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive) -5.10%
06:00AM	Organigram Relaunches one of Canadas First Cannabis Brands, Trailblazer (Business Wire)
Aug-20-23 01:38PM	3 Cannabis Stocks to Snap Up Before They Skyrocket (InvestorPlace)
Aug-15-23 08:52AM	Organigram to Enter the United Kingdom with Agreement to Supply Medical Cannabis to 4C LABS (Business Wire)
Aug-10-23 08:00AM	Organigrams Application for Judicial Review on Jolts Ingestible Extract Granted (Business Wire)

OrganiGram Holdings, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company's global footprint. Its brands include Edison, Big Bag O' Buds, SHRED, Monjour, and Trailblazer. The company was founded on July 5, 2010 and is headquartered in Toronto, Canada.

Institutional Ownership

Tidal Investments LLC	1.37%
RENAISSANCE TECHNOLOGIES LLC	0.73%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	0.57%
AdvisorShares Investments LLC	0.57%
MILLENNIUM MANAGEMENT LLC	0.51%
BANK OF MONTREAL /CAN/	0.36%
DIMENSIONAL FUND ADVISORS LP	0.29%
Baader Bank Aktiengesellschaft	0.20%
GOLDMAN SACHS GROUP INC	0.13%
Formidable Asset Management, LLC	0.13%

Income Statement • Balance Sheet • Cash Flow

Data

Timeframe

Period	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period End Date		9/30/2024	9/30/2023	8/31/2022	8/31/2021	8/31/2020	8/31/2019	8/31/2018
Period Length	12 Months	12 Months	12 Months	Upgrade your FINVIZ experience Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, historical statements, and much more. Learn more
Total Revenue	121.24	117.46	110.64
Cost of Goods Sold Incl. D&A	124.36	122.96	135.71
Gross Profit	-3.13	-5.50	-25.07
Selling, General and Administrative Excl. Other	56.32	58.31	58.28
Research and Development	6.65	8.23	9.04
Other Operating Expense	0.00	0.00	0.00
Operating Income	-59.45	-63.80	-83.35
Interest Expense			0.21
Unusual Expense	-20.97	-31.95	91.11
Net Income Before Taxes	-34.66	-29.51	-172.08
Income Taxes	-0.00	0.00	-2.61
Consolidated Net Income	-38.42	-33.39	-170.16
Net Income From Continuing Operations	-38.42	-33.39	-170.16
Net Income	-38.42	-33.39	-170.16
EPS (Recurring)	-0.47	-0.59	-1.31
EPS (Basic, Before Extraordinaries)	-0.38	-0.35	-2.09
EPS (Diluted)	-0.38	-0.35	-2.09
EBITDA	-50.23	-54.93	-65.42
Price To Earnings Ratio	-2.59	-2.59	-2.72
Price To Sales Ratio		1.47	0.98
Gross Margin	-2.58	-4.68	-22.66
Operating Margin	-49.03	-54.32	-75.34
Net Margin	-31.69	-28.43	-153.80
Shares Outstanding	126.16	108.59	81.16
Market Capitalization	124.60	124.60	191.09

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OGI

OrganiGram Holdings Inc

Target Price and Recommendations

EPS Performance and Forecast

GAAP EPS Performance and Forecast

Revenue Performance and Forecast

Institutional Ownership

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience

Upgrade your FINVIZ experience